Corbus Pharmaceuticals Holdings, Inc. - CRBP
About Gravity Analytica
Recent News
- 02.04.2025 - 4 - Statement of changes in beneficial ownership of securities
- 01.28.2025 - Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference
- 01.08.2025 - Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025
- 01.06.2025 - Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- 12.09.2024 - Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
- 12.03.2024 - 8-K - Current report filing
- 12.03.2024 - FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
- 11.21.2024 - Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
- 11.15.2024 - SC 13G/A - Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions